Page 2 - Ncph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ncph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ncph Today - Breaking & Trending Today

Cipher Pharmaceuticals (TSE:CPH) Given New C$8.00 Price Target at Citigroup

Cipher Pharmaceuticals (TSE:CPH – Get Free Report) (NASDAQ:CPHR) had its target price lifted by research analysts at Citigroup from C$4.75 to C$8.00 in a research note issued to investors on Wednesday, BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Citigroup’s price objective points to a potential upside of 12.68% from the […] ....

Cipher Pharmaceuticals Stock , Cipher Pharmaceuticals , Cipher Pharmaceuticals Inc , News Ratings For Cipher Pharmaceuticals Daily , Get Free Report , Pharmaceuticals Inc , Acute Coronary , Cipher Pharmaceuticals Daily , Tse Cph , Boost Price Target , Citigroup Inc ,

Cipher Pharmaceuticals (TSE:CPH) Hits New 12-Month High at $6.35

Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as C$6.35 and last traded at C$6.23, with a volume of 39301 shares trading hands. The stock had previously closed at C$6.22. Cipher Pharmaceuticals Trading Up 0.6 % […] ....

Cipher Pharmaceuticals Trading , Cipher Pharmaceuticals , News Ratings For Cipher Pharmaceuticals Daily , Cipher Pharmaceuticals Inc , Get Free Report , Pharmaceuticals Inc , Acute Coronary , Cipher Pharmaceuticals Daily , Tse Cph ,

Cipher Pharmaceuticals (TSE:CPH) Reaches New 1-Year High at $6.35

Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s stock price reached a new 52-week high during trading on Monday . The company traded as high as C$6.35 and last traded at C$6.23, with a volume of 39301 shares changing hands. The stock had previously closed at C$6.22. Cipher Pharmaceuticals Trading Up 0.6 % The […] ....

Cipher Pharmaceuticals Trading , Cipher Pharmaceuticals Company Profile , Cipher Pharmaceuticals Inc , News Ratings For Cipher Pharmaceuticals Daily , Cipher Pharmaceuticals , Get Free Report , Pharmaceuticals Inc , Acute Coronary , Cipher Pharmaceuticals Daily , Tse Cph ,

Deciphera Pharma Spikes On Improved Q3 Revenue, Positive Results From Motion Study

Deciphera Pharmaceuticals, Inc. (DCPH) shares are surging more than 23 percent on Monday morning trade after the company announced improved revenue for the third quarter and positive results from its MOTION phase 3 study of Vimseltinib in patients with Tenosynovial giant cell tumor. ....

Deciphera Pharmaceuticals Inc , Deciphera Pharmaceuticals , Stock Alert , Eciphera Pharma ,